Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Looking for Poly L Lactic Acid pharmaceutical excipients? Find information on Poly L Lactic Acid's applications, manufacturers, suppliers, etc. on PharmaCompass.

    Client Email Product

    Poly L Lactic Acid

    • DESCRIPTION

    Suppliers

    SOLUTIONS BY APPLICATIONS

    PharmaCompass
    Previous
    Next
    • DESCRIPTION
    Also known as: L pla , poly l lactide
    Poly(L-lactide) (PLLA) is a biodegradable polymer for pharmaceutical applications.
    Previous
    Next
    ListList of Excipients
    Full View ScreenFull Screen View
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info

    Nomisma Healthcare

      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

      PLLA-PEG

      PDF Supplier PDF
      URL Supplier Web Content
      LM Application #LearnMore
      Applications: PLLA-PEG used in the synthesis of targeted nanoparticles which are used for differential delivery and controlled release of drugs.
      Ingredient(s): Poly L Lactide
      Dosage Form: Tablet
      Category: Controlled & Modified Release
      Route of Administration (Grade): Oral, Parenteral
      Pharmacopoeia Reference: NA
      Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Nomisma Healthcare

        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

        PLLA

        PDF Supplier PDF
        URL Supplier Web Content
        LM Application #LearnMore
        Applications: PLLA (Poly-L-lactide) is different polymer developed to formulate polymeric nanoparticles. PLLA is biodegradable & biocompatible, and it is approved by FDA and European Medicine Agency for parenteral administration.
        Ingredient(s): Poly L Lactide
        Dosage Form: Injectable / Parenteral, Tablet
        Category: Controlled & Modified Release, Parenteral
        Route of Administration (Grade): Oral, Parenteral
        Pharmacopoeia Reference: NA
        Technical Specifications: Nano-particles, ultrapure, low-monomer & powder grades, viscosity range from 0.08 to 1.4 dL/g, ester/acid end group
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Ask Us for Pharmaceutical Supplier and Partner
        Ask Us, Find A Supplier / Partner
        No Commissions, No Strings Attached, Get Connected for FREE

        What are you looking for?

        How can we help you?

        The request can't be empty

        Please read our Privacy Policy carefully

        You must agree to the privacy policy

        The name can't be empty
        The company can't be empty.
        The email can't be empty Please enter a valid email.
        The mobile can't be empty
        veranova-m-2024-04-22

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

        Access Virtual Booth

        Contact Supplier

        View Presentation

        Post Enquiry
        POST ENQUIRY

        Market Place

        Market Place

        PharmaCompass

        Home

        Market Place

        Menu

        Post Enquiry

        Post Enquiry

        Market Place

        Market Place

        Search